|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2003-12-10
|
|
pubmed:abstractText |
To evaluate the clinical efficacy and safety of intravaginal application of 25 microg micronized oestradiol in postmenopausal women from the Greek population suffering from symptoms related to vaginal atrophy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0390-6663
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
30
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
229-34
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:14664420-Administration, Intravaginal,
pubmed-meshheading:14664420-Aged,
pubmed-meshheading:14664420-Analysis of Variance,
pubmed-meshheading:14664420-Atrophy,
pubmed-meshheading:14664420-Dose-Response Relationship, Drug,
pubmed-meshheading:14664420-Drug Administration Schedule,
pubmed-meshheading:14664420-Estradiol,
pubmed-meshheading:14664420-Female,
pubmed-meshheading:14664420-Follow-Up Studies,
pubmed-meshheading:14664420-Greece,
pubmed-meshheading:14664420-Humans,
pubmed-meshheading:14664420-Middle Aged,
pubmed-meshheading:14664420-Postmenopause,
pubmed-meshheading:14664420-Probability,
pubmed-meshheading:14664420-Risk Assessment,
pubmed-meshheading:14664420-Tablets,
pubmed-meshheading:14664420-Treatment Outcome,
pubmed-meshheading:14664420-Vaginal Diseases
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Action of 25 microg 17beta-oestradiol vaginal tablets in the treatment of vaginal atrophy in Greek postmenopausal women; clinical study.
|
|
pubmed:affiliation |
Department of Obstetrics and Gynaecology, G. Chatzikosta General State Hospital, Ioannina, Greece.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study
|
